US Patients Can Now Access Ozempic at Half Price
Novo Nordisk has announced that U.S. patients can now purchase a month’s supply of Ozempic, a widely prescribed diabetes medication, for $499 if they pay out-of-pocket, bypassing insurance coverage. Previously, the drug’s list price approached $1,000 per month, making it financially burdensome for many patients. This initiative aligns with broader calls from policymakers, including […]
Continue Reading